JTC Employer Solutions Trustee Ltd Increases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

JTC Employer Solutions Trustee Ltd raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 31.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,909 shares of the financial services provider’s stock after purchasing an additional 695 shares during the quarter. JTC Employer Solutions Trustee Ltd’s holdings in iShares Biotechnology ETF were worth $401,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. International Assets Investment Management LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth $76,425,000. Global Assets Advisory LLC purchased a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth about $66,059,000. Gray Foundation bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth about $17,890,000. Miller Investment Management LP lifted its position in iShares Biotechnology ETF by 2,394.4% during the 4th quarter. Miller Investment Management LP now owns 90,122 shares of the financial services provider’s stock valued at $12,243,000 after acquiring an additional 86,509 shares during the period. Finally, Gateway Advisory LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth about $9,829,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

IBB traded down $0.93 during midday trading on Wednesday, reaching $135.09. The company’s stock had a trading volume of 1,045,826 shares, compared to its average volume of 1,631,982. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The stock’s 50-day moving average is $134.94 and its 200-day moving average is $134.97.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.